P2 Obesity
Research payments
$3,570,964
Through program year 2023, $3,570,964 in research payments was reported against P2 Obesity, across 34 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $3,570,964 | 34 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Alexander White Port Orange, FL Named on 3 payments
- Kenneth Steil Phoenix, AZ Named on 2 payments
- Joel Neutel Tustin, CA Named on 2 payments
- David Fitz-Patrick Honolulu, HI Named on 2 payments
- Apinya Vutikullird Long Beach, CA Named on 2 payments
- Harold Bays Louisville, KY Named on 2 payments
- Kenneth Kim Long Beach, CA Named on 2 payments
- Mark Christiansen Walnut Creek, CA Named on 2 payments
- Kathryn Lucas Morehead City, NC Named on 1 payment
- James Swain Scottsdale, AZ Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.